The fiscal stability of the global gastrointestinal market is heavily influenced by the interplay between rising healthcare expenditures and government-mandated cost-containment measures. The Proton Pump Inhibitors Market Economic Outlook suggests a steady CAGR of 5.6%, with the global market valuation projected to reach nearly $6 billion by 2032. This growth is underpinned by the massive...